Susquehanna International Group
KRBP

Susquehanna International Group’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Susquehanna International Group’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,457
Closed -$64.2K – 13764
2023
Q1 		$64.2K Buy
+16,457
New +$87K ﹤0.01% 11578
2022
Q3 		– Sell
-343
Closed -$4K – 14569
2022
Q2 		$4K Buy
+343
New +$5.41K ﹤0.01% 12644
2022
Q1 		– Sell
-639
Closed -$18.9K – 14371
2021
Q4 		$29K Buy
+639
New +$43.5K ﹤0.01% 12755

Other funds holding KRBP

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group's KRBP Position: Q2 2023 in Review

Susquehanna International Group sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q2 2023, closing a stake of 16,457 shares — an estimated $64.2K sold.

Susquehanna International Group first reported a position in KRBP in Q4 2021 and held it in 3 quarters. The position peaked at $64.2K in Q1 2023. 5 funds tracked by Wall St. Rank hold KRBP as of Q2 2023.

  • Susquehanna International Group reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 16,457 Kiromic BioPharma, Inc. Common Stock shares in Q2 2023, an estimated $64.2K.
  • Susquehanna International Group first reported a position in Kiromic BioPharma, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Susquehanna International Group's Kiromic BioPharma, Inc. Common Stock position peaked at $64.2K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.